À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ºÍ²³½¡Ðû²¼£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÒÑÏòÖйú¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾ÖÌá½»ÂØ¿¨Ä¹£¨lecanemab£¬¿ª·¢´úºÅ: BAN2401£©ÉÏÊÐÉêÇë£¬ÂØ¿¨Ä¹ÊÇ°¢¶û´Äº£Ä¬²¡£¨AD£©ËùÖÂÇá¶ÈÈÏÖªÕÏ°­£¨MCI£©ºÍÇá¶ÈAD(ͳ³ÆΪÔçÆÚAD)µÄ¿¹µí·ÛÑùÂÑ°× (A¦Â) Ô­ÏËά¿¹Ìå¡£

ÂØ¿¨Ä¹µÄÉêÇëÀà±ðΪһÀàÐÂÒ©£¨Î´ÔÚÖйú»òÈκÎÆäËû¹ú¼ÒÅú×¼µÄ´´ÐÂÒ©£©¡£

ÂØ¿¨Ä¹Ñ¡ÔñÐԵؽáºÏ²¢Ïû³ý¿ÉÈÜÐÔ¡¢¶¾ÐÔµí·ÛÑù¦Â£¨A¦Â£©¾Û¼¯Ì壨ԭÏËά£©£¬ÕâЩ¾Û¼¯Ìå±»ÈÏΪµ¼ÖÂADµÄÉñ¾­±äÐÔ¹ý³Ì¡£Òò´Ë£¬ÂØ¿¨Ä¹½«»á¶Ô¼²²¡²¡Àíѧ·¢ÉúÓ°Ïì£¬²¢¼õ»º¼²²¡µÄ½øÕ¹¡£Clarity ADÑо¿µÄÂØ¿¨Ä¹µ½´ïÁËÖ÷ÒªÖÕµãºÍËùÓÐÒªº¦µÄ´ÎÒªÖÕµã£¬½á¹û¾ßÓÐÏÔÖøͳ¼ÆѧÒâÒå¡£2022Äê11ÔÂ£¬Clarity ADÑо¿µÄ½á¹ûÔÚ2022Äê°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑ飨CTAD£©»áÒéÉÏÐû²¼£¬²¢Í¬Ê±·¢±íÔÚÊÀ½ç×îÖøÃûµÄͬÐÐÆÀÉóҽѧÔÓÖ¾¡¶ÐÂÓ¢¸ñÀ¼Ò½Ñ§ÔÓÖ¾¡·ÉÏ¡£

ÔÚÃÀ¹ú£¬ÂØ¿¨Ä¹·Ö±ðÓÚ2021Äê6ÔºÍ12Ô±»ÃÀ¹úʳƷºÍÒ©Îï¹ÜÀí¾Ö£¨FDA£©ÊÚÓèÍ»ÆÆÐÔÁÆ·¨ºÍ¿ìËÙͨµÀµÄ³Æν¡£2022Äê7ÔÂ£¬FDAÔÚ¿ìËÙͨµÀÈ϶¨Ï½ÓÊÜÁËÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾µÄÂØ¿¨Ä¹µÄÉúÎïÖÆÆ·Ðí¿ÉÉêÇ루BLA£©£¬²¢ÊÚÓèÆäÓÅÏÈÉó²éȨ¡£´¦·½Ò©Óû§Óöȷ¨°¸µÄÐж¯£¨PDUFA£©ÈÕÆÚ¶¨ÓÚ2023Äê1ÔÂ6ÈÕ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾µÄÄ¿±êÊÇÔÚ2022²ÆÕþÄê¶È½áÊøÇ°£¬ÔÚÃÀ¹úÉêÇëÍêÈ«Åú×¼£¬ÔÚÈÕ±¾ºÍÅ·ÖÞÉêÇëÉÏÊÐÐí¿É¡£

ÂØ¿¨Ä¹µÄÈ«Çò¿ª·¢ºÍ¼à¹ÜÌá½»ÓÉÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Ö÷µ¼£¬¶ø²úÎïÔòÓÉÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ºÍ²³½¡ÅäºÏÉÌÒµ»¯ºÍÍƹã£¬ÆäÖÐÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓµÓÐ×îÖÕ¾ö²ßȨ¡£

 

Contacts
MEDIA CONTACT: Eisai Co., Ltd. Public Relations Department TEL: +81-(0)3-3817-5120     INVESTOR CONTACT: Eisai Co., Ltd. Investor Relations Department TEL: +81-(0)3-3817-5122	MEDIA CONTACT: Biogen Inc. Natacha Gassenbach + 1-857-777-6573 public.affairs@biogen.com   INVESTOR CONTACT: Biogen Inc. Mike Hencke + 1-781-464-2442 IR@biogen.com